Abstract:1477 Objectives Noninvasive detection of apoptosis may play an important role in the evaluation of therapy efficiency and disease progression. In this study, we aim to develop Annexin A5-functionalized nanoparticles for dual optical/nuclear imaging of apoptosis. Methods Poly (ethylene glycol) (PEG)-coated, core-crosslinked polymeric micelles (CCPM) were dual-labeled with a near-infrared fluorescence fluorophores (Cy7) and a radioisotope (111In). CCPM nanoparticles were conjugated with Annexin A5. To evaluate the specificity of Annexin A5-CCPM to apoptotic cells, three different preclinical models of apoptosis, including a tumor model, a liver apoptosis model, and an inflammation model were carried out. Results In mice bearing EL4 lymphoma treated with cyclophosphamide and etoposide, the tumor apoptosis was clearly visualized by both SPECT and fluorescence molecular tomography after i.v. administration of 111In-labeled Annexin A5-CCPM. In contrast, there was little accumulation of this nanoradiotracer in the tumors of untreated mice. The biodistribution data was consistent with the imaging data. In liver apoptosis model, the apoptotic liver induced by anti-Fas antibody was clearly visualized by both nuclear and optical images. In contrast, significantly lower signals were detected in healthy livers of untreated mice after injection of 111In-labeled Annexin A5-CCPM and in apoptotic livers after injection of 111In-labeled CCPM. Similarly, 111In-labeled Annexin A5-CCPM showed a significantly higher uptake in the site of inflammation induced by intramuscular injection of turpentine (4.9 %ID/g) than that in the healthy site (0.6 %ID/g). Moreover, in all three models, histological analysis revealed colocalization between radioactivity and fluorescence signals from the nanoparticles, and drug-induced apoptosis. Conclusions Annexin A5-CCPM allowed visualization of apoptosis by both nuclear and optical techniques. The complementary information acquired with multiple imaging techniques should be advantageous in assessing and validating early response to therapy

Progress in Imaging Agents of Cell Apoptosis

Progress on molecular imaging for apoptosis

Radionuclide imaging of apoptosis for clinical application

Research Progress of Radionuclide Imaging Probes in Apoptosis

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

Advance in apoptosis imaging with annexins in tumor research

Development Progress of Apoptosis Imaging with Radioactive Annexin V

In vivo detection of apoptotic cell death: a necessary measurement for evaluating therapy for myocarditis, ischemia, and heart failure

Molecular Function Imaging of Cell Apoptosis

In Vivo Stem Cell Imaging

A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis

High Sensitivity Real‐Time Fluorescence Microscopy and its Application in Thymocyte Apoptosis (abstract)

Apoptosis detection for adherent cell populations in time-lapse phase-contrast microscopy images.

Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy

Multiplexed imaging detection of live cell intracellular changes in early apoptosis with aggregation-induced emission fluorogens

In vivo fluorescence imaging: success in preclinical imaging paves the way for clinical applications

Annexin A5-functionalized nanoparticles for in vivo dual modality imaging of apoptosis

The first visualization of chemotherapy-induced tumor apoptosis via magnetic particle imaging in a mouse model

Progress in Imaging in Vivo Based on Microrna

Targeting Apoptosis for Optical Imaging of Infection

Study of the Relationship Between Apoptosis and Intracellular Ph in Single Living Cells Using a Three-Channel Real-Time Fluorescence Imaging Method